Immunology and Microbiology
Bcl-2
100%
Upregulation
100%
P53
100%
Experimental Model
100%
Downregulation
100%
Lung Adenocarcinoma Cell Line
100%
Programmed Cell Death
100%
Keyphrases
Apoptotic Pathway
100%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
100%
MiR-125b
100%
MicroRNA
25%
Knockdown
16%
Attenuation
8%
Overexpressing
8%
Tumorigenesis
8%
B-cell Lymphoma 2 (Bcl-2)
8%
Non-small Cell Lung Cancer (NSCLC)
8%
Overexpression
8%
Apoptosis
8%
Colorectal Cells
8%
P53 Expression
8%
Patient Samples
8%
Bona Fide
8%
In Vitro Data
8%
Poor Prognosis
8%
Pleiotropic Effects
8%
Inverse Correlation
8%
Anti-apoptotic
8%
Oncology Setting
8%
Aggressive Tumor
8%
Matrix Metalloproteinases
8%
Gastric Cells
8%
Breast Cells
8%
Natural Inhibitors
8%
Angiogenic Activity
8%
Pharmacology, Toxicology and Pharmaceutical Science
Tissue Inhibitor of Metalloproteinase 1
100%
microRNA
25%
Lung Adenocarcinoma
16%
Neoplasm
8%
Carcinogenesis
8%
Protein P53
8%
Non Small Cell Lung Cancer
8%
Antiapoptotic
8%
Matrix Metalloproteinase
8%
Tissue Inhibitor of Metalloproteinase
8%